Log In
Print this Print this

Lucentis sustained delivery

  Manage Alerts
Collapse Summary General Information
Company Genentech Inc.
DescriptionDrug delivery device designed to provide sustained delivery of Lucentis
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetic macular edema (DME)
Indication DetailsTreat diabetic macular edema (DME)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today